FIELD: medicine.
SUBSTANCE: subject 1 is a water-in-oil (w/o) emulsion formulation for tumour treatment containing 3 types of peptides having 4 linked CTL epitopes, each containing 4 CTL peptide epitopes linked via linkers in the aqueous phase. Subject 2 is a process for obtaining an emulsion composition. Subject 3 is a device used to obtain an emulsion composition. Subject 3 is a set used to obtain an emulsion composition. Subject 5 is a process for treating a tumour in a patient, including administration of the emulsion composition to the patient. Subject 6 is using the emulsion composition for the treatment of tumours. Subject 7 is using a solution of peptides with 4 associated CTL epitopes in the production of an emulsion composition. Subject 8 is a process for obtaining an emulsion composition.
EFFECT: obtaining a stable water-in-oil (w/o) emulsion composition within a short period of time.
16 cl, 5 dwg, 5 tbl, 7 ex
| Title |
Year |
Author |
Number |
| ANTITUMOR AGENT AND A METHOD OF ITS EVALUATION |
2019 |
|
RU2803148C2 |
| NEW PEPTIDE WITH 4 LINKED CTL-EPITHOPES |
2014 |
- Fukaya Satosi
- Osada Tosikhiro
- Vada Khirosi
|
RU2636549C1 |
| NOVEL PEPTIDE WITH 5 LINKED CTL EPITOPES |
2014 |
- Fukaya Satosi
- Osada Tosikhiro
- Vada Khirosi
- Utsugi Terukhiro
|
RU2627175C2 |
| FELAMENTOUS FUNGI CELL WITH PROTEASE DEFICIT AND METHODS OF ITS APPLICATION |
2013 |
- Landovski Kristofer
- Khuuskonen Anne
- Saarinen Yukhani
- Vesterkholm-Parvinen Ann
- Kanerva Anne
- Natunen Yari
- Khyanninen Anna-Liisa
- Salovuori Noora
- Penttilya Merya
- Salokhejmo Markku
|
RU2645252C2 |
| NEIL3 PEPTIDES AND VACCINES COMPRISING THEM |
2010 |
- Tsunoda, Takuya
- Ohsawa, Ryuji
- Yoshimura, Sachiko
- Watanabe, Tomohisa
- Nakamura, Yusuke
- Furukawa, Yoichi
|
RU2733985C2 |
| PEPTIDE IMMUNOGENS AND COMPOSITIONS CONTAINING SAID IMMUNOGENS TARGETING MEMBRANE-BOUND IGE FOR TREATING IGE-MEDIATED ALLERGIC DISEASES |
2017 |
- Wang, Chang Yi
- Lin, Feng
- Chen, Jiun Bo
|
RU2769983C2 |
| FUSION CONSTRUCTION CONTAINING CELL PENETRATING PEPTIDE, POLYEPITOPE AND TLR PEPTIDE AGONIST, INTENDED FOR TREATMENT OF CANCER |
2017 |
- Derouazi Madiha
- Belnoue Elodie
|
RU2807135C2 |
| IL-31 PEPTIDE IMMUNOGENS AND THEIR COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF ADOPIC DERMATITIS |
2018 |
|
RU2799440C2 |
| TAU-PEPTIDE IMMUNOGENIC CONSTRUCTS |
2018 |
|
RU2798972C2 |
| PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND COMPOSITIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES AFFECTED BY IMPAIRED IL-6 REGULATION |
2019 |
- Wang, Chang, Yi
- Lin, Feng
- Chen, Jiun, Bo
- Ding, Shuang
|
RU2780161C1 |
